Nick Ballew

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Replacement Therapy

Peritoneal Dialysis

Disease Activity

Ejection Fraction

Top Venues

Lupus science & medicine

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Nick Ballew, Aneela Mian, Roger Abramino Levy, Matt Bradley
Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research 12 (1) (2022)
Nick Ballew, Aneela Mian, Roger Abramino Levy, Matt Bradley
Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research (2022)
Nick Ballew, Aneela Mian, Roger Abramino Levy, Matt Bradley
Letter to the Editor: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research 12 (1) (2022)